Leerink Partnrs Has Positive Outlook of Immunic Q2 Earnings
Immunic, Inc. (NASDAQ:IMUX – Free Report) – Leerink Partnrs raised their Q2 2025 earnings per share (EPS) estimates for shares of Immunic in a research note issued to investors on Wednesday, April 30th. Leerink Partnrs analyst F. Khurshid now forecasts that the company will post earnings per share of ($0.16) for the quarter, up from […]
Immunic, Inc. (NASDAQ:IMUX – Free Report) – Leerink Partnrs raised their Q2 2025 earnings per share (EPS) estimates for shares of Immunic in a research note issued to investors on Wednesday, April 30th. Leerink Partnrs analyst F. Khurshid now forecasts that the company will post earnings per share of ($0.16) for the quarter, up from […]
